Paper30630705
A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.
Kraguljac NV and 7 others. Schizophr Res, 2019. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. Papers, record 30630705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30630705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Glutamic Acid | Major topic |
| Gyrus Cinguli | Major topic |
| Hippocampus | Major topic |
| Risperidone | Major topic |
| Schizophrenia | Major topic |
| Adult | |
| Female | |
| Humans | |
| Longitudinal Studies | |
| Magnetic Resonance Spectroscopy | |
| Male | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 MH106683 | NIMH NIH HHS | United States | K23MH106683 | PubMed and NIH | NIH RePORTER |
| R01 MH081014 | NIMH NIH HHS | United States | R01MH081014 | PubMed and NIH | NIH RePORTER |
| R01 MH102951 | NIMH NIH HHS | United States | R01MH102951 | PubMed and NIH | NIH RePORTER |
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26333842 | Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia. | Schizophr Bull | 2016 | https://conductscience.org/library/papers/26333842 | PubMed |
| 2 | 27304221 | Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies. | JAMA Psychiatry | 2016 | https://conductscience.org/library/papers/27304221 | PubMed |
| 3 | 12679238 | Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. | Biol Psychiatry | 2003 | https://conductscience.org/library/papers/12679238 | PubMed |
| 4 | 26873890 | Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study. | Schizophr Bull | 2016 | https://conductscience.org/library/papers/26873890 | PubMed |
| 5 | 25045268 | The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study. | Neuropsychiatr Dis Treat | 2014 | https://conductscience.org/library/papers/25045268 | PubMed |
| 6 | 12718446 | Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs. | Neurochem Res | 2003 | https://conductscience.org/library/papers/12718446 | PubMed |
| 7 | 28503156 | Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies. | Front Psychiatry | 2017 | https://conductscience.org/library/papers/28503156 | PubMed |
| 8 | 25449711 | GABAergic mechanisms of hippocampal hyperactivity in schizophrenia. | Schizophr Res | 2015 | https://conductscience.org/library/papers/25449711 | PubMed |
| 9 | 25786581 | The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study. | Neuropsychopharmacology | 2015 | https://conductscience.org/library/papers/25786581 | PubMed |
| 10 | 28243459 | Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T. | BJPsych Open | 2017 | https://conductscience.org/library/papers/28243459 | PubMed |
| 11 | 25045047 | Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia. | Hippocampus | 2014 | https://conductscience.org/library/papers/25045047 | PubMed |
| 12 | 10978720 | Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II. | Biol Psychiatry | 2000 | https://conductscience.org/library/papers/10978720 | PubMed |
| 13 | 18094668 | Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia. | Neuropsychopharmacology | 2008 | https://conductscience.org/library/papers/18094668 | PubMed |
| 14 | 22805603 | Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. | Neuropsychopharmacology | 2012 | https://conductscience.org/library/papers/22805603 | PubMed |
| 15 | 7492260 | Glutamate receptor dysfunction and schizophrenia. | Arch Gen Psychiatry | 1995 | https://conductscience.org/library/papers/7492260 | PubMed |
| 16 | 10839330 | Decisional capacity for informed consent in schizophrenia research. | Arch Gen Psychiatry | 2000 | https://conductscience.org/library/papers/10839330 | PubMed |
| 17 | 25732147 | Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia. | Curr Mol Med | 2015 | https://conductscience.org/library/papers/25732147 | PubMed |
| 18 | 26905411 | Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes. | Transl Psychiatry | 2016 | https://conductscience.org/library/papers/26905411 | PubMed |
| 19 | 24418122 | Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. | Schizophr Res | 2014 | https://conductscience.org/library/papers/24418122 | PubMed |
| 20 | 19239984 | Creatine abnormalities in schizophrenia and bipolar disorder. | Psychiatry Res | 2009 | https://conductscience.org/library/papers/19239984 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40954276 | Cerebral glutamate levels over two years in initially antipsychotic-naïve first-episode patients with psychosis are related to clinical symptoms and cognition. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/40954276 | PubMed |
| 39927517 | Changes in glutamate levels in anterior cingulate cortex following 16 weeks of antipsychotic treatment in antipsychotic-naïve first-episode psychosis patients. | Psychol Med | 2025 | https://conductscience.org/library/papers/39927517 | PubMed |
| 39833308 | Mapping the cellular etiology of schizophrenia and complex brain phenotypes. | Nat Neurosci | 2025 | https://conductscience.org/library/papers/39833308 | PubMed |
| 39580605 | A longitudinal study of hippocampal subfield volumes and hippocampal glutamate levels in antipsychotic-naïve first episode psychosis patients. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/39580605 | PubMed |
| 39145348 | Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk. | Schizophr Bull Open | 2023 | https://conductscience.org/library/papers/39145348 | PubMed |
| 38600117 | Higher-order functional brain networks and anterior cingulate glutamate + glutamine (Glx) in antipsychotic-naïve first episode psychosis patients. | Transl Psychiatry | 2024 | https://conductscience.org/library/papers/38600117 | PubMed |
| 38429320 | Reduction of N-acetyl aspartate (NAA) in association with relapse in early-stage psychosis: a 7-Tesla MRS study. | Schizophrenia (Heidelb) | 2024 | https://conductscience.org/library/papers/38429320 | PubMed |
| 38419937 | Resting state and activated brain glutamate-glutamine, brain lactate, cognition, and psychopathology among males with schizophrenia: A 3 Tesla proton magnetic resonance spectroscopic (1H-MRS) study. | Indian J Psychiatry | 2024 | https://conductscience.org/library/papers/38419937 | PubMed |
| 37752221 | Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex. | Neuropsychopharmacology | 2024 | https://conductscience.org/library/papers/37752221 | PubMed |
| 37406595 | Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status. | Neuroimage Clin | 2023 | https://conductscience.org/library/papers/37406595 | PubMed |
| 37253720 | The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment. | Transl Psychiatry | 2023 | https://conductscience.org/library/papers/37253720 | PubMed |
| 36752830 | Hippocampal Hyperconnectivity to the Visual Cortex Predicts Treatment Response. | Schizophr Bull | 2023 | https://conductscience.org/library/papers/36752830 | PubMed |
| 36463316 | Glutamatergic dysfunction in Schizophrenia. | Transl Psychiatry | 2022 | https://conductscience.org/library/papers/36463316 | PubMed |
| 36456813 | Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration. | Neuropsychopharmacology | 2023 | https://conductscience.org/library/papers/36456813 | PubMed |
| 36237115 | Dorsal striatial hypoconnectivity predicts antipsychotic medication treatment response in first-episode psychosis and unmedicated patients with schizophrenia. | Brain Behav | 2022 | https://conductscience.org/library/papers/36237115 | PubMed |
| 36032237 | The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A 1H-MRS study in first-episode psychosis patients. | Front Psychiatry | 2022 | https://conductscience.org/library/papers/36032237 | PubMed |
| 34999898 | White Matter Metabolite Relaxation and Diffusion Abnormalities in First-Episode Psychosis: A Longitudinal Study. | Schizophr Bull | 2022 | https://conductscience.org/library/papers/34999898 | PubMed |
| 34933941 | A multimodal neuroimaging study investigating resting-state connectivity, glutamate and GABA at 7 T in first-episode psychosis. | J Psychiatry Neurosci | 2021 | https://conductscience.org/library/papers/34933941 | PubMed |
| 34829575 | Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia? | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34829575 | PubMed |
| 34662778 | Salience network glutamate and brain connectivity in medication-naïve first episode patients - A multimodal magnetic resonance spectroscopy and resting state functional connectivity MRI study. | Neuroimage Clin | 2021 | https://conductscience.org/library/papers/34662778 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DRD2 | 1813 | PubTator's text mining | https://conductscience.org/library/genes/1813 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30630705
GET https://conductscience.org/api/papers/v1/30630705/references?page=2